The use of fluorescence in situ hybridization analysis on sperm: indications to perform and assisted reproduction technology outcomes
- 146 Downloads
To determine the consequences of an altered sperm fluorescence in situ hybridization (FISH) result for ART outcomes and the indications for a sperm FISH analysis.
Data from 439 infertile men were collected. Bivariate analyses were performed to determine the association of men’s age, seminal alterations, and sperm FISH indication, with the incidence of X, Y, 13, 18, and 21 sperm chromosomal abnormalities. A multivariate logistic regression analysis was performed to establish the most predictive variables for altered sperm FISH. Results from the IVF/ICSI cycles were collected for 248 out of 439 patients. Two distinct groups were established: 151 couples that used their own oocytes and 97 couples involved in egg donation programs. In both groups, ART outcomes were compared between normal and altered sperm FISH.
Teratozoospermia and oligozoospermia were associated with sperm chromosome anomalies (p < 0.05). Indications for sperm FISH analysis with the highest predictability were teratozoospermia, male age, oligozoospermia, and implantation failure (AUC = 0.702). Embryo quality (p = 0.096), pregnancy rate (p = 0.054), and implantation rate (p = 0.089) were higher in own-oocytes couples with normal sperm FISH than in altered sperm FISH couples, although differences were not statistically significant. In donor-oocytes couples, in which high-quality embryos were transferred later than in own-oocytes couples (3.8 vs. 3.0 days), we did not identify differences in the ART outcome between normal and altered sperm FISH couples. In both groups, the possible interference of woman age was negligible.
Sperm FISH is indicated in middle-aged oligoteratozoospermic patients with implantation failures in previous IVF/ICSI cycles. Sperm chromosome anomalies have a moderate detrimental impact on embryo quality, implantation, and pregnancy rates.
KeywordsART outcome Blastocyst transfer Male age Seminal parameters Sperm FISH indications
The authors thank the Applied Statistics Service of the Universitat Autònoma de Barcelona for its support in the statistical treatment of the results. This manuscript has been proofread by Proof-Reading-Service.org.
Compliance with ethical standards
The Ethics Commission on Human and Animal Experimentation of the Universitat Autònoma de Barcelona approved the study.
- 6.Ioannou D, Fortun J, Tempest HG. Meiotic nondisjunction and sperm aneuploidy in humans. Reproduction 2018;R15-R31. doi: https://doi.org/10.1530/REP-18-0318.
- 7.Sarrate Z, Anton E. Fluorescence in situ hybridization (FISH) protocol in human sperm. J Vis Exp. 2009;31:1405. https://doi.org/10.3791/1405.
- 17.World Health Organization. WHO laboratory manual for the examination and processing of human semen. 5th ed. Switzerland: WHO Press; 2010.Google Scholar
- 18.ASEBIR. (Asociación para el estudio de la Biología de la Reproducción). Cuadernos de Embriología Clínica. II. Criterios de valoración morfológicos de oocitos, embriones tempranos y blastocitos humanos. 3rd ed. Spain: ASEBIR; 2015.Google Scholar
- 21.Royal College of Obstetricians and Gynaecologists. The investigation and treatment of couples with recurrent first-trimester and second-trimester miscarriage (Green-Top Guideline no. 17). London: RCOG Press; 2011.Google Scholar
- 56.Huang ZQ, Wang GX, Jiang XL, Tian EP, Yao WL, Zeng T. Systematic tracking of altered modules identifies disrupted pathways in teratozoospermia. Genet Mol Res 2016;15. doi https://doi.org/10.4238/gmr.15027514.
- 59.Aran B, Blanco J, Vidal F, Vendrell JM, Egozcue S, Barri PN, et al. Screening for abnormalities of chromosomes X, Y, and 18 and for diploidy in spermatozoa from infertile men participating in an in vitro fertilization-intracytoplasmic sperm injection program. Fertil Steril. 1999;72:696–701.CrossRefPubMedPubMedCentralGoogle Scholar
- 68.Ioannou D, Tempest HG. Does genome organization matter in spermatozoa? A refined hypothesis to awaken the silent vessel. Syst Biol Reprod Med. 2018;2:1–17.Google Scholar
- 76.Mazzilli R, Cimadomo D, Vaiarelli A, Capalbo A, Dovere L, Alviggi E, et al. Effect of the male factor on the clinical outcome of intracytoplasmic sperm injection combined with preimplantation aneuploidy testing: observational longitudinal cohort study of 1,219 consecutive cycles. Fertil Steril. 2017;108:961–72.CrossRefGoogle Scholar
- 77.Geraedts JPM. Chromosomal anomalies and recurrent miscarriage. Infertil Reprod Med Clin North Am. 1996;7:677–88.Google Scholar